Yue Lu

Title: Yue Lu: Innovator in Thienopyrimidine Compounds

Introduction

Yue Lu is a prominent inventor based in Xiamen, China. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on thienopyrimidine compounds. Her research focuses on developing compounds that have selective inhibitory activity against ALK and/or c-Met, which are crucial in treating various diseases.

Latest Patents

Yue Lu holds a patent for a thienopyrimidine compound, which includes a preparation method, pharmaceutical composition, and its applications. The invention relates to compounds that exhibit selective inhibitory activity against anaplastic lymphoma kinase (ALK) and c-Met. This patent outlines a method for preparing these compounds and their use in manufacturing medicaments aimed at preventing or treating diseases associated with ALK, angiogenesis, or cancer metastasis. The compounds are particularly relevant in the context of tumor growth and metastasis.

Career Highlights

Throughout her career, Yue Lu has worked with notable organizations, including Hongyun Biotech Co., Ltd. and Xiamen University. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Yue Lu has collaborated with esteemed colleagues such as Xianming Deng and Baoding Zhang. These partnerships have enhanced her research efforts and broadened the impact of her work in the field of pharmaceuticals.

Conclusion

Yue Lu's innovative contributions to thienopyrimidine compounds highlight her role as a key inventor in the pharmaceutical industry. Her work not only advances scientific knowledge but also has the potential to improve treatment options for patients facing serious health challenges.